| Company Name: |
J & K SCIENTIFIC LTD.
|
| Tel: |
010-82848833 400-666-7788 |
| Email: |
jkinfo@jkchemical.com |
| Products Intro: |
Product Name:(S)-Lisinopril-d5
CAS:1356905-39-9
Package:10Mg,1Mg
|
| Company Name: |
3B Pharmachem (Wuhan) International Co.,Ltd.
|
| Tel: |
821-50328103-801 18930552037 |
| Email: |
3bsc@sina.com |
| Products Intro: |
Product Name:(S)Lisinopril-D5
Purity:99% HPLC Package:1Mg ; 5Mg;10Mg ;100Mg;250Mg ;500Mg ;1g;2.5g ;5g ;10g
|
| Company Name: |
Cato Research Chemicals Inc.
|
| Tel: |
020-81960175 |
| Email: |
min.he@cato-chem.com |
| Products Intro: |
Product Name:(S)-Lisinopril-d5
CAS:1356905-39-9
Purity:95% Package:25Mg, 50Mg
|
- Lisinopril- D5
-
- $0.00 / 5mg
-
2023-05-27
- CAS:1356905-39-9
- Min. Order: 1mg
- Purity: 96%
- Supply Ability: 50mg
|
| | (S)Lisinopril-D5 Basic information |
| | (S)Lisinopril-D5 Chemical Properties |
| storage temp. | Store at -20°C | | solubility | Methanol: soluble; Water: soluble | | form | A solid | | CAS DataBase Reference | 1356905-39-9 |
| | (S)Lisinopril-D5 Usage And Synthesis |
| Description | Lisinopril-d5 is intended for use as an internal standard for the quantification of lisinopril by GC- or LC-MS. Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor (IC50 = 1.2 nM). It reduces the formation of endothelin-1 and increases nitric oxide in human vascular endothelial cells. Lisinopril inhibits the pressor response to angiotensin I in anesthetized rats and dogs (ID50s = 2.3 and 6.5 μg/kg in rat and dog, respectively). | | Chemical Properties | White to Off-White Crystalline Powder | | Uses | (S)-Lisinopril-d5 is a labeled analogue of (S)-Lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor. | | Uses | Labelled Lisinopril, intended for use as an internal standard for the quantification of Lisinopril by GC- or LC-mass spectrometry | | Uses | (S)Lisinopril-D5 can be Labeled , it is an orally active angiotensin-converting enzyme (ACE) inhibitor , intended for use as an internal standard for the quantification of Lisinopril by GC- or LC-mass spectrometry. |
| | (S)Lisinopril-D5 Preparation Products And Raw materials |
|